The WHO-ESCEO Innovation Award
The Aging and Health Unit at WHO Headquarters and the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases decided to distinguish a Corporate Partner who has developed a new strategy/device/algorithm/tools/chemical entity/technology, recognized for its innovation, that will significantly contribute to a better management of patients presenting with age-related musculoskeletal conditions. For 2026, the WHO-ESCEO Innovation Award will be presented to a member of the Precompetitive Consortium on Osteoporosis and Bone Health (PRECCO), i.e. the stakeholders who support the 5-year Partnership signed between ESCEO and the World Health Organization to improve the management of Osteoporosis.
Applications should reach Mr. Martin Scheffer (scheffer@humacom.com) no later than January 31st, 2026.
The innovation should be presented during the WCO 2026 under the form at least two scientific abstracts submitted to the WCO-IOF-ESCEO Website (https://www.wco-iof-esceo.org/abstracts).
Applications will be validated if a copy of the two (or more) submitted abstracts are joined to the submission. The application should contain a maximum of 3 A4 pages summarizing why the proposed strategy/device/algorithm/tools/clinical entity/technology represents a novelty to the field of musculoskeletal health, significantly contributing to a better management of the patients.
The selection of the 2026 winner will be made an independent jury constituted by:
- Doctor Jotheeswaran Amuthavalli Thiyagarajan (WHO) (Chairman of the Jury)
- Doctor Sameer Pujari (WHO)
- Professor René Rizzoli (Chairman, Scientific Advisory Board ESCEO)
The WHO-ESCEO Innovation Award will be presented during the Opening Ceremony of the WCO-IOF-ESCEO 2026 Congress in Prague, by Doctor Jotheeswaran Amuthavalli Thiyagarajan.